Clinical Trial Update: A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer [Phase 1]

View source ↗

Summary

An ongoing Phase 1 clinical trial is evaluating valemetostat in combination with atezolizumab for extensive-stage small cell lung cancer. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• valemetostat (valemetostat)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Extensive-stage Small-cell Lung Cancer | Phase 1 | Status: RECRUITING